1. Home
  2. CASI vs CKX Comparison

CASI vs CKX Comparison

Compare CASI & CKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • CKX
  • Stock Information
  • Founded
  • CASI 1991
  • CKX 1930
  • Country
  • CASI China
  • CKX United States
  • Employees
  • CASI N/A
  • CKX N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • CKX Oil & Gas Production
  • Sector
  • CASI Health Care
  • CKX Energy
  • Exchange
  • CASI Nasdaq
  • CKX Nasdaq
  • Market Cap
  • CASI 20.5M
  • CKX 22.6M
  • IPO Year
  • CASI 1996
  • CKX 1998
  • Fundamental
  • Price
  • CASI $2.36
  • CKX $11.31
  • Analyst Decision
  • CASI Strong Buy
  • CKX
  • Analyst Count
  • CASI 1
  • CKX 0
  • Target Price
  • CASI $4.00
  • CKX N/A
  • AVG Volume (30 Days)
  • CASI 3.7M
  • CKX 5.0K
  • Earning Date
  • CASI 09-02-2025
  • CKX 08-08-2025
  • Dividend Yield
  • CASI N/A
  • CKX N/A
  • EPS Growth
  • CASI N/A
  • CKX N/A
  • EPS
  • CASI N/A
  • CKX 0.18
  • Revenue
  • CASI $31,368,000.00
  • CKX $835,960.00
  • Revenue This Year
  • CASI N/A
  • CKX N/A
  • Revenue Next Year
  • CASI N/A
  • CKX N/A
  • P/E Ratio
  • CASI N/A
  • CKX $63.35
  • Revenue Growth
  • CASI 8.39
  • CKX N/A
  • 52 Week Low
  • CASI $1.09
  • CKX $10.04
  • 52 Week High
  • CASI $7.67
  • CKX $14.00
  • Technical
  • Relative Strength Index (RSI)
  • CASI 64.70
  • CKX 44.29
  • Support Level
  • CASI $1.95
  • CKX $11.10
  • Resistance Level
  • CASI $3.09
  • CKX $12.00
  • Average True Range (ATR)
  • CASI 0.34
  • CKX 0.19
  • MACD
  • CASI 0.07
  • CKX -0.11
  • Stochastic Oscillator
  • CASI 55.21
  • CKX 31.07

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.

Share on Social Networks: